Learn to better recognize posterior segment damage and minimize patient risk.
Suspicious retinal lesions indicate idiopathic sclerochoroidal calcification.
ODs respond to recent articles and columns. See what they have to say.
Diplopia, headaches and blurry near vision made homework a chore for this young man.
Can this patient’s fundus exam reveal the cause of his visual distortion?
Knowing the possible reasons behind the resurgence of this common corneal disease is half the battle.
Patients with emergency presentations may not recognize the signs of Horner’s syndrome, but you can, using these clinical pearls.
With our annual disease guide, Drs. Sowka, Kabat and Gurwood take center stage.
You can still keep up on the latest up-and-coming drugs.
Spots and vision loss in the right eye. What's the diagnosis?
Some issues, both ocular and systemic, have a greater impact on women than men.
In the case of filamentary keratitis, should one eye drop be used over the other?
When a patient gets an allergic reaction to glaucoma drops, it’s time to BAK off.
Why you should customize treatment to the specific form of anterior blepharitis.
Help patient's understand what comes after the discovery of a pituitary tumor.
Want to express meibomian glands like a pro? Here’s a step-by-step tutorial.
VEP helped solve the mystery of a patient’s optic nerve pallor.
Which medicines can complicate vision?
When you see follicular conjunctivitis, think adenovirus.
Arm yourself with the latest advice to keep patients healthy.
Tonometry tips to help you develop a trusty technique.
Decreased vision at near and a lump in her neck. What's the diagnosis?
Researchers link visual field results and risk of falls in glaucoma patients.
Here’s 10 medications in the pipeline.
What do you do when symptoms and objective testing don’t agree?
A routine slit lamp exam may reveal telltale findings of health concerns elsewhere in the body.
A new study says azithromycin better improves signs and symptoms—at a lower price.
Today’s optometrists face difficult Rx decisions.
Blurry vision after an auto accident. What's the diagnosis?
Here is a snapshot of what's happening in the industry.
If ASP doesn’t do the job, here’s a more aggressive option.
This condition can affect more than just the eyelids.
Can this old-school measure hold its own in a more sophisticated era?
From the Snellen chart to the surgical suite, and everywhere in between.
Reestablishing a pH balance is key to controlling ocular damage from chemical burns.
Eyelid exams can be critical to keeping your patients healthy.
A slow-release delivery system improves treatment for CNV in mouse eyes.
Seeing spots leads to a diagnosis of idiopathic juxtafoveal retinal telangiectasis.
Can this patient’s fundus exam help you find the cause of her sudden loss of vision?
Steps to perform lacrimal dilation and irrigation.
Off-label uses present us with dilemmas to navigate on a daily basis.
Recognize when a situation calls for doctors to revert to old-model drugs.
Don't mistake this complex condition for a more typical ocular surface disorder.
Copious eye washing is the necessary first step in combating chemical splashes.
The new squalamine looks to improve outcomes, potentially expanding the OD's role.
Because of the close association between optic neuritis and MS, a prompt diagnosis and referral for treatment is paramount.
Here’s a review of the most commonly prescribed topical and oral antiviral medications used to manage herpetic eye disease.
Here is a snapshot of what is happening in the industry.
How do ocular vitamins match up to their claims?
A new bill could reinstate ODs' privileges to prescribe hydrocodone.
Using drugs off label is not only permissible, it’s often standard of care. Get to know the following non-FDA-approved indications (if you don’t know them already).
Herpes, HIV, Ebola, enterovirus and rhinovirus (the common cold) are but a few notable examples.
Oral antibiotics and analgesics often are clinically necessary when treating certain ocular conditions. Here’s a rundown of our favorite systemic agents.
Be sure to watch for these rare but disastrous adverse ocular effects in patients on
EGFR inhibitors who are being treated for cancer.
A review of the latest product offerings.
A common blood pressure medication may hold the key to treating diabetes.
Our patient with a history of rheumatoid arthritis reported a steady loss of vision.
Was her medication to blame?
Thyroid eye disease is complex and confounding. This comprehensive review connects the pathophysiology to its clinical presentation.
We've heard about these presentations, but have yet to actually see them.
A review of the latest product offerings.
Eylea provides a longer duration of effect for diabetic macular edema patients than other anti-VEGF options.
It's a common condition. What, if anything, can be done to identify and treat it?
For anti-VEGF treatment of AMD, monthly frequency and ranibizumab treatment were associated with a higher risk of geographic atrophy.
Optometrists are increasingly involved in recommending—and even performing—PIs. Here, an Oklahoma OD walks us through the procedure.
A decade ago, we looked at the latest treatment options for blepharitis. It's high time we eye them up again.
This patient returned after uncomplicated cataract surgery with an unexpected "correction" to his glaucoma. How did this happen?
Three non-routine cataract cases showcase surgical advances and highlight increasing postoperative visual expectations.
In some instances, properly medicating a patient may lead to other problems.
When ocular inflammation is too severe to manage with NSAIDs or steroids alone, consider an amniotic membrane graft.
Transzonular drug delivery during cataract surgery is a safe, convenient way to quash concerns about postoperative drug compliance.
Hydroxychloroquine (Plaquenil, Sanofi-Aventis) therapy is no better than placebo in patients with primary Sjögren’s syndrome.
Even Cleopatra would favor this simple, needle-based procedure.
This uveitis patient is also a steroid responder. Which problem do you tackle first?
Is there a role for iridotomy when managing patients with pigmentary glaucoma?